# SONOMA PHARMACEUTICALS, INC. (SNOA) · Edgar & Edgarette company card

> Sonoma Pharmaceuticals (SNOA) grew revenue 36.7% in FY2026 to $20 million, operating margin -12.6% against a 1.2% median for surgical & medical instruments & apparatus, equity 22.2% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1367083 · fiscal year ended 2026-03-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/SNOA) · [JSON](https://www.pops4.com/boards/company/SNOA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $20M |
| Revenue growth, 1 year | 36.7% |
| Revenue growth per year | 11.5% |
| Operating margin | -12.6% (prior year -26.0%) |
| Net margin | -16.3% |
| Operating cash flow | −$4M |
| Capital spending | $192,000 |
| Free cash flow | −$4M |
| Cash | $2M |
| Long-term debt | — |
| Total assets | $14M |
| Total equity | $3M |
| Equity ÷ assets | 22.2% |
| Return on equity | -102.6% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -44.4 (distress zone)
- Piotroski F: 3 of 9 (middling)
- Beneish M: -1.69 (above the −1.78 line)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative; operating loss: a margin of -12.6% in FY2026; revenue is hard to predict: its 80% range is ±47%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $19.5M (FY2026). Experience: revenue up 36.7% on the year, up 11.5% a year over 4 years; operating margin -12.6%, up from -26.0%. Soundness: equity 22.2% of assets, return on equity -102.6%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $14.5M and $39.7M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $13.5M to $42.7M. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -12.6% against a 1.2% median; growth 36.7% against 11.6%.

Range logged 2026-09-29, receipt 7370a61372ee02b9, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-01-28 ([filing](https://www.sec.gov/Archives/edgar/data/1367083/000168316826000589/0001683168-26-000589-index.htm))

## Recent filings

- 8-K · filed 2026-10-06 · 1.01 Entry into a Material Definitive Agreement; 3.03 Material Modifications to Rights of Security Holders; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1367083/000168316826007657/0001683168-26-007657-index.htm)
- 8-K · filed 2026-09-17 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1367083/000168316826007199/0001683168-26-007199-index.htm)
- 8-K · filed 2026-08-19 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1367083/000168316826006608/0001683168-26-006608-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/1367083/000168316826006024/0001683168-26-006024-index.htm)
- DEF 14A · filed 2026-07-28 · [filing](https://www.sec.gov/Archives/edgar/data/1367083/000168316826005810/0001683168-26-005810-index.htm)
- 8-K · filed 2026-06-18 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1367083/000168316826004975/0001683168-26-004975-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001367083.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1367083

## Cite

POPS4, Edgar & Edgarette: SONOMA PHARMACEUTICALS, INC. (SNOA) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/SNOA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.